@kiromic.com
Percent of Cancer deaths in the US potentially treatable by immunotherapy drugs
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Kiromic is a pioneering brand in the field of biopharmaceuticals, revolutionizing the way we approach cancer treatment. With a strong focus on immunotherapy, Kiromic aims to develop innovative and effective solutions to combat cancer. By leveraging the power of CAR-T therapy, Kiromic is at the forefront of scientific advancements in the fight against cancer.
Their cutting-edge technology pipeline is designed to target a wide range of cancers, with the potential to treat a staggering 70% of cancer deaths in the US. Unlike traditional cancer therapies, Kiromic's immunotherapy drugs offer a new ray of hope for patients, providing them with a potentially life-saving alternative. However, Kiromic recognizes the challenges faced by patients, as conventional cancer treatments often come with undesirable side effects.
That's why they are dedicated to minimizing toxicities and off-target effects that harm normal cells, ensuring a higher rate of success and improved quality of life for patients. With state-of-the-art facilities and labs, Kiromic is committed to driving breakthroughs in cancer research and delivering impactful solutions. As a brand, Kiromic is dedicated to improving the lives of patients and transforming the future of cancer treatment
Company Type
Public Company
Company Size
51-200
Year Founded
2012
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories